Quipt Home Medical Corp. reiterates outlook for 2022. Based on the current operations, market trends and completed and prospective acquisitions, the Company is reiterating it outlook for its annual run-rate revenue by the end of calendar 2022 (Fiscal First Quarter 2023) to be $180-$190 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 CAD | -0.23% | -3.72% | -34.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.81% | 136M | |
+26.08% | 88.38B | |
-23.66% | 77.56B | |
+8.73% | 28.74B | |
+7.45% | 18.45B | |
-13.80% | 16.57B | |
+2.60% | 15.81B | |
+78.26% | 13.65B | |
+82.29% | 13.06B | |
+3.66% | 12.61B |
- Stock Market
- Equities
- QIPT Stock
- News Quipt Home Medical Corp.
- Quipt Home Medical Corp. Reiterates Outlook for 2022